Janus Kinase 2, an Early Target of α7 Nicotinic Acetylcholine Receptor-mediated Neuroprotection against Aβ-(1–42) Amyloid
Open Access
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (47), 44920-44924
- https://doi.org/10.1074/jbc.m204610200
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout miceBritish Journal of Pharmacology, 2001
- β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neuronsProceedings of the National Academy of Sciences, 2001
- Nicotinic treatment of Alzheimer’s diseaseBiological Psychiatry, 2001
- Effects of nicotine on APP secretion and Aβ- or CT105-induced toxicityBiological Psychiatry, 2001
- Nicotinic receptor abnormalities in Alzheimer’s diseaseBiological Psychiatry, 2001
- The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)Behavioural Brain Research, 2000
- Blockade of JAK2 by Tyrphostin AG-490 Inhibits Antigen-Induced Eosinophil Recruitment into the Mouse AirwaysBiochemical and Biophysical Research Communications, 2000
- In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418Brain Research, 1996
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- Angiofensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's diseaseEuropean Journal of Pharmacology, 1991